Kurt Tong is managing partner at The Asia Group and a former senior U.S. diplomat who served in Japan and other Asian economies. Alexandra Melillo is an associate vice president at The Asia Group.
Since 2022, the Japanese government has made efforts to adjust some policies that negatively impact the pharmaceutical market and have slowed patient access to innovative medicines.
